Evidence map›Paper›PMID 26749456›Full record

ArticleBrazilian journal of otorhinolaryngology

Polymorphisms in methylenetetrahydrofolate reductase and cystathionine beta-synthase in oral cancer - a case-control study in southeastern Brazilians.

Andressa Barbosa, Marcelo Dos Santos, José Roberto Vasconcelos de Podestá, Sônia Alves Gouvêa, Sandra Ventorin Von Zeidler, Iúri Drumond Louro, Melissa de Freitas Cordeiro-Silva

Open access · goldAbstract read
In one paragraph

Article in Brazilian journal of otorhinolaryngology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Association ofOncoTargets and therapy · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Andressa BarbosaUniversidade Federal do Espírito Santo (UFES), Departamento de Ciências Biológicas, Vitória, ES, Brazil.
Marcelo Dos SantosUniversidade Federal do Espírito Santo (UFES), Departamento de Ciências Biológicas, Vitória, ES, Brazil.
José Roberto Vasconcelos de PodestáHospital Santa Rita de Cássia, Divisão de Cirurgia de Cabeça e Pescoço, Programa de Prevenção e Detecção Precoce de Câncer Oral, Vitória, ES, Brazil.
Sônia Alves GouvêaUniversidade Federal do Espírito Santo (UFES), Departamento de Ciências Fisiológicas, Vitória, ES, Brazil.
Sandra Ventorin Von ZeidlerUniversidade Federal do Espírito Santo (UFES), Departamento de Patologia, Vitória, ES, Brazil.
Iúri Drumond LouroUniversidade Federal do Espírito Santo (UFES), Departamento de Ciências Biológicas, Vitória, ES, Brazil.
Melissa de Freitas Cordeiro-SilvaFaculdade Católica Salesiana do Espírito Santo, Vitória, ES, Brazil. Electronic address: melissafcs@yahoo.com.br.
Universidade Federal do Espírito Santo · BRFundação de Amparo à Pesquisa do Espírito Santo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionOral squamous cell carcinoma (OSCC) is a serious public health problem, due to its high mortality rate and worldwide rising incidence. OSCC susceptibility is mediated by interactions between genetic and environmental factors. Studies suggest that genetic variants encoding enzymes involved in folate metabolism may modulate OSCC risk by altering DNA synthesis/repair and methylation process.

objectiveThe goals of this study were to evaluate the association of three genotypic polymorphism (MTHFR C677T, MTHFR A1298C and CBS 844ins68) and oral cancer risk in southeastern Brazilians and evaluate the interactions between polymorphisms and clinical histopathological parameters.

methodsThis case-control study included 101 cases and 102 controls in the state of Espírito Santo, Brazil. MTHFR genotyping was done by PCR-RFLP (polymerase chain reaction - restriction fragment length polymorphism) and CBS genotyping by PCR (polymerase chain reaction) analysis.

resultsMTHFR C677T polymorphism was associated with lymph node involvement. Genotype CT+TT acted as a protective factor. MTHFR A1298C AC+CC genotype was associated with tumor differentiation, and possibly with a better prognosis. In risk analysis, no correlation was observed between genotypes and OSCC.

conclusionWe concluded that MTHFR C677T, MTHFR A1298C and CBS 844ins68 polymorphisms were not associated with OSCC risk in southeastern Brazilians; however, we suggest a prognosis effect associated with MTHFR C677T and A1298C polymorphisms in OSCC.

Indexed as

AdultCarcinoma, Squamous CellCase-Control StudiesCystathionine beta-SynthaseFemaleGenetic Predisposition to DiseaseGenotypeHumansMaleMethylenetetrahydrofolate Reductase (NADPH2)Middle AgedMouth NeoplasmsNeoplasm StagingPolymerase Chain ReactionPolymorphism, Restriction Fragment LengthPrognosisCystathionine beta-SynthaseMethylenetetrahydrofolate Reductase (NADPH2)Carcinoma epidermoide oralCistationina beta-sintaseCystathionine beta-synthaseGenetic polymorphismMethylenetetrahydrofolate reductaseMetilenotetrahidrofolato redutaseOral squamous cell carcinomaPolimorfismo genético

Identifiers

PMID26749456
PMCPMC9444640
OpenAlexW2203945325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.